{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:50:58Z","timestamp":1777560658330,"version":"3.51.4"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"S1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Union Sixth framework program","award":["2SHC-CT-2004-503306"],"award-info":[{"award-number":["2SHC-CT-2004-503306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00005-016-0437-3","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T13:39:26Z","timestamp":1484228366000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression"],"prefix":"10.2478","volume":"64","author":[{"given":"Snezhina Mihailova","family":"Kandilarova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Paschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastassia","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissaveta","family":"Naumova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"437_CR1","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/ncomms6639","volume":"5","author":"TH Ali","year":"2014","unstructured":"Ali TH, Pisanti S, Ciaglia E et al (2014) Enrichment of CD56(dim)KIR\u00a0+\u00a0CD57\u00a0+\u00a0highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun 5:5639","journal-title":"Nat Commun"},{"key":"437_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","volume":"7","author":"AA Bashirova","year":"2006","unstructured":"Bashirova AA, Martin MP, McVicar DW et al (2006) The killer immunoglobulinlike receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7:277\u2013300","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"437_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0198-8859(02)00802-9","volume":"64","author":"S Becker","year":"2003","unstructured":"Becker S, Tonn T, Fussel T et al (2003) Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous kir expression independent of anticipated HLA class I ligands. Hum Immunol 64:183\u2013193","journal-title":"Hum Immunol"},{"key":"437_CR4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00002371-200003000-00013","volume":"23","author":"MP Bettinotti","year":"2000","unstructured":"Bettinotti MP, Norris RD, Hackett JA et al (2000) Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing. J Immunother 23:282\u2013287","journal-title":"J Immunother"},{"key":"437_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962012000100001","volume":"87","author":"RR Bonamigo","year":"2012","unstructured":"Bonamigo RR, Carvalho AV, Sebastiani VR et al (2012) HLA and skin cancer. An Bras Dermatol 87:9\u201318","journal-title":"An Bras Dermatol"},{"key":"437_CR6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0161-5890(02)00030-5","volume":"38","author":"JC Boyington","year":"2002","unstructured":"Boyington JC, Sun PD (2002) A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 38:1007\u20131021","journal-title":"Mol Immunol"},{"key":"437_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","volume":"149","author":"RJ Boyton","year":"2007","unstructured":"Boyton RJ, Altmann DM (2007) Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 149:1\u20138","journal-title":"Clin Exp Immunol"},{"key":"437_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00251-013-0682-0","volume":"65","author":"JA Campillo","year":"2013","unstructured":"Campillo JA, Legaz I, L\u00f3pez-\u00c1lvarez MR et al (2013) KIR gene variability in cutaneous malignant melanoma: influence of KIR2D\/HLA-C pairings on disease susceptibility and prognosis. Immunogenetics 65:333\u2013343","journal-title":"Immunogenetics"},{"key":"437_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ijc.24082","volume":"124","author":"M Carlsten","year":"2009","unstructured":"Carlsten M, Malmberg KJ, Ljunggren HG (2009) Natural killer cell-mediated lysis of freshly isolated human tumor cells. Int J Cancer 124:757\u2013762","journal-title":"Int J Cancer"},{"key":"437_CR10","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.20051473","volume":"202","author":"S Chen","year":"2005","unstructured":"Chen S, Kawashima H, Lowe JB et al (2005) Suppression of tumor formation in lymph nodes by l-selectin-mediated natural killer cell recruitment. J Exp Med 202:1679\u20131689","journal-title":"J Exp Med"},{"key":"437_CR11","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/eji.200838434","volume":"38","author":"M Della Chiesa","year":"2008","unstructured":"Della Chiesa M, Romeo E, Falco M et al (2008) Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 38:2284\u20132289","journal-title":"Eur J Immunol"},{"key":"437_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.25270","volume":"127","author":"F Garrido","year":"2010","unstructured":"Garrido F, Cabrera T, Aptsiauri N (2010) \u201cHard\u201d and \u201csoft\u201d lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy. Int J Cancer 127:249\u2013256","journal-title":"Int J Cancer"},{"key":"437_CR13","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1002\/cncr.25211","volume":"116","author":"H Gogas","year":"2010","unstructured":"Gogas H, Kirkwood JM, Falk CS et al (2010) Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon. Cancer 116:4326\u20134333","journal-title":"Cancer"},{"key":"437_CR14","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D et al (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 39:D913\u2013D919","journal-title":"Nucleic Acid Res"},{"key":"437_CR15","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.4049\/jimmunol.158.11.5237","volume":"158","author":"JE Gumperz","year":"1997","unstructured":"Gumperz JE, Barber LD, Valiante NM et al (1997) Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 158:5237\u20135241","journal-title":"J Immunol"},{"key":"437_CR16","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/eji.200425089","volume":"34","author":"P Hansasuta","year":"2004","unstructured":"Hansasuta P, Dong T, Thananchai H et al (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34:1673\u20131679","journal-title":"Eur J Immunol"},{"key":"437_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","volume":"214","author":"SI Khakoo","year":"2006","unstructured":"Khakoo SI, Carrington M (2006) KIR and disease: a model system or system of models? Immunol Rev 214:186\u2013201","journal-title":"Immunol Rev"},{"key":"437_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","volume":"436","author":"S Kim","year":"2005","unstructured":"Kim S, Poursine-Laurent J, Truscott SM et al (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709\u2013713","journal-title":"Nature"},{"key":"437_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","volume":"11","author":"HG Ljunggren","year":"1990","unstructured":"Ljunggren HG, Karre K (1990) In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition. Immunol Today 11:237\u2013244","journal-title":"Immunol Today"},{"key":"437_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00251-010-0477-5","volume":"62","author":"MP Martin","year":"2010","unstructured":"Martin MP, Borecki IB, Zhang Z et al (2010) HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics 62:761\u2013765","journal-title":"Immunogenetics"},{"key":"437_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/0008-5472.CAN-13-1303","volume":"74","author":"M Messaoudene","year":"2014","unstructured":"Messaoudene M, Fregni G, Fourmentraux-Neves E et al (2014) Mature cytotoxic CD56(bright)\/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma. Cancer Res 74:81\u201392","journal-title":"Cancer Res"},{"key":"437_CR22","first-page":"1166","volume":"11","author":"JA Metzelaar-Blok","year":"2005","unstructured":"Metzelaar-Blok JA, Hurks HM, Naipal A et al (2005) Normal HLA class I, II, and MICA gene distribution in uveal melanoma. Mol Vis 11:1166\u20131172","journal-title":"Mol Vis"},{"key":"437_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-0039.2006.00792.x","volume":"69","author":"D Middleton","year":"2007","unstructured":"Middleton D, Vilchez JR, Cabrera T et al (2007) Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens 69:220\u2013226","journal-title":"Tissue Antigens"},{"key":"437_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/157339408784310070","volume":"4","author":"A Mihaylova","year":"2008","unstructured":"Mihaylova A, Mihailova S, Naumova E (2008) NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies. Currt Cancer Ther Rev 4:130\u2013136","journal-title":"Currt Cancer Ther Rev"},{"key":"437_CR25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","volume":"14","author":"A Moretta","year":"1996","unstructured":"Moretta A, Bottino C, Vitale M et al (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619\u2013648","journal-title":"Annu Rev Immunol"},{"key":"437_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00262-004-0575-z","volume":"54","author":"E Naumova","year":"2005","unstructured":"Naumova E, Mihaylova A, Stoitchkov K et al (2005) Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 54:172\u2013178","journal-title":"Cancer Immunol Immunother"},{"key":"437_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00262-006-0151-9","volume":"56","author":"E Naumova","year":"2007","unstructured":"Naumova E, Mihaylova A, Ivanova M et al (2007) Impact of KIR\/HLA ligand combinations on immune responses in malignant melanoma. Cancer Immunol Immunother 56:95\u2013100","journal-title":"Cancer Immunol Immunother"},{"key":"437_CR28","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","volume":"173","author":"GW Nelson","year":"2004","unstructured":"Nelson GW, Martin MP, Gladman D et al (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173:4273\u20134276","journal-title":"J Immunol"},{"key":"437_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002510000281","volume":"52","author":"PJ Norman","year":"2001","unstructured":"Norman PJ, Stephens HA, Verity DH et al (2001) Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52:195\u2013205","journal-title":"Immunogenetics"},{"key":"437_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","volume":"5","author":"P Parham","year":"2005","unstructured":"Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201\u2013214","journal-title":"Nat Rev Immunol"},{"key":"437_CR31","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20050499","volume":"201","author":"S Rajagopalan","year":"2005","unstructured":"Rajagopalan S, Long EO (2005) Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201:1025\u20131029","journal-title":"J Exp Med"},{"key":"437_CR32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/annonc\/mdj138","volume":"17","author":"D Schadendorf","year":"2006","unstructured":"Schadendorf D, Ugurel S, Schuler-Thurner B et al (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 17:563\u2013570","journal-title":"Ann Oncol"},{"key":"437_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood-2010-03-273656","volume":"117","author":"K Sch\u00f6nberg","year":"2011","unstructured":"Sch\u00f6nberg K, Sribar M, Enczmann J et al (2011) Analyses of HLA-C-specific KIR repertoires in donors with group A and acquisition B haplotypes suggest a ligand-instructed model of NK cell receptor. Blood 117:98\u2013107","journal-title":"Blood"},{"key":"437_CR34","unstructured":"Terasaki P, Gjertson D (1997) HLA. In: Ferencik S, Grosse-Wilde H UCLA Tissue Typing Laboratory (1st edn), pp 222\u2013223"},{"key":"437_CR35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1399-0039.2001.057004358.x","volume":"57","author":"M Toneva","year":"2001","unstructured":"Toneva M, Lepage V, Lafay G et al (2001) Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57:358\u2013362","journal-title":"Tissue Antigens"},{"key":"437_CR36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","volume":"7","author":"M Uhrberg","year":"1997","unstructured":"Uhrberg M, Valiante NM, Shum BP et al (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753\u2013763","journal-title":"Immunity"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-016-0437-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T19:28:41Z","timestamp":1718998121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-016-0437-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s00005-016-0437-3","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}